Log in
NYSE:NEW

Puxin Stock Forecast, Price & News

$7.39
-0.10 (-1.34 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$7.18
Now: $7.39
$7.60
50-Day Range
$7.04
MA: $8.91
$9.90
52-Week Range
$3.62
Now: $7.39
$12.39
Volume329,578 shs
Average Volume363,432 shs
Market Capitalization$643.16 million
P/E RatioN/A
Dividend YieldN/A
Beta2.01
Puxin Limited, through its subsidiaries, provides after-school education services in China. It offers a range of K-12 and study-abroad tutoring programs designed to help students prepare for admission tests and applications for top schools, universities, and graduate programs in China and other countries. The company also provides group class courses; personalized tutoring courses; English tutoring services for children in kindergarten; and extra-curricular courses to students, such as painting, calligraphy, music, debate, and science, as well as offers Web-based and mobile-based platforms for K-12 tutoring services. In addition, it sells education materials; and provides advertisement, study consulting, and training services. As of March 31, 2018, the company had a network of 397 learning centers; and 4 schools providing extra-curricular education courses. Puxin Limited was founded in 2014 and is headquartered in Beijing, China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars

Industry, Sector and Symbol

Industry Educational services
Sub-IndustryN/A
CUSIP6435EV108
Phone86-10-8260-5578
Employees11,732

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$445.86 million
Book Value$0.43 per share

Profitability

Net Income$-74,480,000.00

Miscellaneous

Market Cap$643.16 million
Next Earnings Date11/16/2020 (Estimated)
OptionableOptionable
$7.39
-0.10 (-1.34 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NEW News and Ratings via Email

Sign-up to receive the latest news and ratings for NEW and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Puxin (NYSE:NEW) Frequently Asked Questions

How has Puxin's stock price been impacted by Coronavirus?

Puxin's stock was trading at $7.03 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEW stock has increased by 5.1% and is now trading at $7.39.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Puxin?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Puxin in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Puxin
.

When is Puxin's next earnings date?

Puxin is scheduled to release its next quarterly earnings announcement on Monday, November 16th 2020.
View our earnings forecast for Puxin
.

How were Puxin's earnings last quarter?

Puxin Limited (NYSE:NEW) posted its earnings results on Monday, August, 24th. The company reported $0.06 earnings per share for the quarter. The company earned $85.07 million during the quarter. Puxin had a negative return on equity of 4.46% and a negative net margin of 2.62%.
View Puxin's earnings history
.

What guidance has Puxin issued on next quarter's earnings?

Puxin updated its third quarter 2020 Pre-Market earnings guidance on Monday, August, 24th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $115.611-122.659 million.

Who are some of Puxin's key competitors?

What other stocks do shareholders of Puxin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Puxin investors own include Ampio Pharmaceuticals (AMPE), Trevena (TRVN), K12 (LRN), Pfizer (PFE), Advanced Micro Devices (AMD), ChromaDex (CDXC), Chimerix (CMRX), CorMedix (CRMD), CTI BioPharma (CTIC) and DRDGOLD (DRD).

Who are Puxin's key executives?

Puxin's management team includes the following people:
  • Mr. Yunlong Sha, Founder, Chairman & CEO (Age 42)
  • Mr. Peng Wang, Chief Financial Officer (Age 41)

When did Puxin IPO?

(NEW) raised $133 million in an initial public offering (IPO) on Friday, June 15th 2018. The company issued 7,200,000 shares at a price of $17.00-$20.00 per share. Citigroup, Deutsche Bank Securities, Barclays, Haitong International and CICC served as the underwriters for the IPO.

What is Puxin's stock symbol?

Puxin trades on the New York Stock Exchange (NYSE) under the ticker symbol "NEW."

Who are Puxin's major shareholders?

Puxin's stock is owned by a variety of institutional and retail investors. Top institutional investors include TB Alternative Assets Ltd. (2.98%) and Resources Investment Advisors LLC. (0.01%).

Which major investors are selling Puxin stock?

NEW stock was sold by a variety of institutional investors in the last quarter, including TB Alternative Assets Ltd., and Resources Investment Advisors LLC..

How do I buy shares of Puxin?

Shares of NEW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Puxin's stock price today?

One share of NEW stock can currently be purchased for approximately $7.39.

How big of a company is Puxin?

Puxin has a market capitalization of $643.16 million and generates $445.86 million in revenue each year. Puxin employs 11,732 workers across the globe.

What is Puxin's official website?

The official website for Puxin is www.pxjy.com.

How can I contact Puxin?

Puxin's mailing address is FLOOR 16 CHUANGFU MANSION NO. 18 DANLING STREET HAIDIAN DISTRICT, BEIJING F4, 100080. The company can be reached via phone at 86-10-8260-5578 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.